These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3276478)

  • 1. Treatment of allergy to heterologous monocomponent insulin with human semisynthetic insulin. Long-term study.
    Bruni B; Barolo P; Blatto A; Carlini M; Ansaldi SG; Grassi G
    Diabetes Care; 1988 Jan; 11(1):59-62. PubMed ID: 3276478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-specific IgE in serum of 67 diabetic patients against human insulin (Novo), porcine insulin, and bovine insulin. Four case reports.
    Falholt K; Hoskam JA; Karamanos BG; Süsstrunk H; Viswanathan M; Heding LG
    Diabetes Care; 1983; 6 Suppl 1():61-5. PubMed ID: 6343042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lispro analog for treatment of generalized allergy to human insulin.
    Kumar D
    Diabetes Care; 1997 Sep; 20(9):1357-9. PubMed ID: 9283778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and allergenic potential of animal and human insulins.
    Schernthaner G
    Diabetes Care; 1993 Dec; 16 Suppl 3():155-65. PubMed ID: 8299472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A twelve month double-blind randomized study of the efficacy and immunogenicity of human and porcine insulins in non-insulin-dependent diabetics.
    HO LT; Lam HC; Wu MS; Kwok CF; Jap TS; Tang KT; Wang LM; Liu YF
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):313-9. PubMed ID: 1649672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance and allergy to recombinant human insulin.
    Ganz MA; Unterman T; Roberts M; Uy R; Sahgal S; Samter M; Grammer LC
    J Allergy Clin Immunol; 1990 Jul; 86(1):45-51. PubMed ID: 2196303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immediate type allergy to insulin (author's transl)].
    Velcovsky HG; Beringhoff B; Federlin K
    Immun Infekt; 1978 Aug; 6(4):146-52. PubMed ID: 150399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of human insulin in cases of insulin allergy].
    Gerö L; Kerényi Z; Bányai Z; Tamás G
    Orv Hetil; 1989 May; 130(22):1159-62. PubMed ID: 2668841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgE-mediated allergy to recombinant human insulin in a diabetic.
    Baur X; Bossert J; Koops F
    Allergy; 2003 Jul; 58(7):676-8. PubMed ID: 12823131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of insulin allergy: the crystalline human insulin may mask its antigenicity.
    Takatsuki H; Ishii H; Yamauchi T; Nakashima N; Nagase S; Hisatomi A; Umeda F; Nawata H
    Diabetes Res Clin Pract; 1991 May; 12(2):137-9. PubMed ID: 1879305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of complement activation and consumption in diabetic children and adolescents after switch-over from porcine to semisynthetic human insulin.
    Dorchy H; Duchateau J; D'Hooge D
    Diabete Metab; 1988; 14(4):415-21. PubMed ID: 3066649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE and IgG antibody against human (recombinant DNA) insulin in patients with systemic insulin allergy.
    Grammer LC; Roberts M; Patterson R
    J Lab Clin Med; 1985 Jan; 105(1):108-13. PubMed ID: 3881543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin allergy: reaginic antibodies to insulin and proinsulin.
    Kumar D; Rosenquist RJ; Parameswaran V
    J Clin Endocrinol Metab; 1979 Aug; 49(2):252-4. PubMed ID: 457844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed-type allergy against various insulin preparations including human semisynthetic insulin.
    Würzburger MI; Prelević GM; Despotović N; Vucković S; Brkić SD; Bozović M; Nastić-Mirić D
    Ann Allergy; 1987 Jul; 59(1):44-7. PubMed ID: 3300437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin allergy treated with human insulin (recombinant DNA).
    De Leeuw I; Delvigne C; Bekaert J
    Diabetes Care; 1982; 5 Suppl 2():168-70. PubMed ID: 6765530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.